Integrin beta-3 (ITGB3 or CD61) Antibody

About the Target

Build reproducible readouts by using this antibody to characterize Integrin beta-3 (CD61) across matched sample sets. Integrin beta-3 is an extracellular or receptor-linked component that coordinates matrix engagement with cytoskeletal remodeling. Use matched handling so differences reflect biology rather than processing.

In some datasets and protocols, it is referenced by the gene symbol CD61.

Research Context

Perturbations that disrupt integrin engagement or actomyosin tension can reshape localization and complex assembly. Define inclusion criteria and controls early so replicate sets remain interpretable as the dataset grows.

Consider these angles when interpreting target-level changes:

• remodeling after changes in substrate or mechanical stress
• co-variation with cytoskeletal and scaffold partners
• focal adhesion versus diffuse membrane distribution
• effects of adhesion inhibitors or matrix composition

Variant Considerations

When assay conditions are still being tuned, a regular-format antibody supports stepwise adjustment of buffers and incubation steps. This matters because epitope exposure and background can vary with preparation and extraction steps. Standardize key parameters so differences reflect biology rather than handling.

To support downstream analysis, record key context variables (culture timing, stimulation window, and extraction approach) so Integrin beta-3 patterns can be compared across experiments without guesswork.

If your study spans multiple model systems, it can help to define a shared reference condition for Integrin beta-3 so cross-sample contrasts stay meaningful.

For multi-run studies, the regular format option helps keep Integrin beta-3 (CD61) trends comparable from experiment to experiment.